Atlas Trials

Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin

Clinical trial NCT00516750 · TERMINATED

Trial details

NCT number
NCT00516750
Sponsor
Kyoto University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2007-07-01
Primary completion
2009-02-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.